Sasha Ruiz-Torres
Affiliations: | 2013-2018 | Cancer Biology | University of Cincinnati, Cincinnati, OH |
Google:
"Sasha Ruiz-Torres"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ruiz-Torres SJ, Bourn JR, Benight NM, et al. (2021) Macrophage-mediated RON signaling supports breast cancer growth and progression through modulation of IL-35. Oncogene |
| Bourn JR, Ruiz-Torres SJ, Hunt BG, et al. (2021) Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling. Cancer Letters. 503: 75-90 |
| Zhou Z, Jafari M, Sriram V, et al. (2017) Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. Molecular Pharmaceutics |
| Ruiz-Torres SJ, Benight NM, Karns RA, et al. (2017) HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling. Oncotarget. 8: 58918-58933 |
| Zhou Z, Kennell C, Jafari M, et al. (2017) Sequential Delivery of Erlotinib and Doxorubicin for Enhanced Triple Negative Breast Cancer Treatment Using Polymeric Nanoparticle. International Journal of Pharmaceutics |
| Gurusamy D, Ruiz-Torres SJ, Johnson AL, et al. (2014) Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis. Mechanisms of Development. 133: 11-22 |